Japanese Nobel laureate settles with Ono Pharma over Opdivo suit

Settlement to go as donation to Kyoto University, where Tasuku Honjo is professor

Japanese Nobel laureate and Kyoto University professor Tasuku Honjo has sued Ono Pharmaceutical over the distribution of patent royalties related to cancer immunotherapy Opdivo.

Nikkei staff writers

November 12, 2021 16:04 JST

OSAKA -- Japanese Nobel laureate Tasuku Honjo and drugmaker Ono Pharmaceutical reached a settlement on Friday in a lawsuit over the distribution of patent royalties related to cancer immunotherapy Opdivo.

The company will pay Honjo 5 billion yen ($43.8 million) to settle the dispute, and donate 23 billion yen to a fund to be set up at Kyoto University to finance research and education.